We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Sugar Supplement Fuels the Failing Heart

By HospiMedica staff writers
Posted on 03 Apr 2007
D-ribose, a simple, five-carbon sugar, has been shown to improve functional capacity, quality of life, and everyday activities for patients afflicted with congestive heart failure (CHF).

D-Ribose, unlike glucose, is a 5-carbon monosaccharide (pentose sugar) important for DNA, RNA, and most importantly, adenosine tri-phosphate (ATP), the energy currency of the cells. More...
ATP is crucial in maintaining the integrity and function of every cell, which is necessary for day-to-day health. By helping to replenish ATP supply, ribose increases cardiac energy reserves that become depressed during ischemia or hypoxia associated with coronary artery disease (CAD) or CHF by improving diastolic function.

Bioenergy Ribose is a dietary additive for energy enhancement. About 2-5 gm are generally adequate for added energy. To maximize athletic performance, assist CHF patients, or to keep energy pools high during strenuous activity, slightly larger doses may be required. Bioenergy Ribose, a product of Bioenergy Life Science (Minneapolis, MN, USA), is a mildly sweet, completely soluble food supplement. It mixes easily with juice, milk, or other cold foods.

"The number of heart failure patients continues to grow every year. By replenishing ATP to an energy-deficient heart we can significantly improve a patient's quality of life,” said John St. Cyr, M.D., Ph.D., medical director of Bioenergy Life Science. "We've learned recently that patients with heart disease may have a deficient supply of high energy compounds. Past studies have demonstrated that D-ribose supplementation enhances the return of ATP levels with an associated improvement in diastolic function.”

In the body, ribose is made from glucose (a simple six-carbon sugar) through a pathway called the pentose phosphate pathway (PPP) or hexose monophosphate shunt (HMS). The physiologically functional form of ribose, called 5-phosphoribosyl-1-pyrophosphate (PRPP), regulates the metabolic pathway that synthesizes energy compounds in all living tissue.


Related Links:
Bioenergy Life Science

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.